On average, patients using these medications can achieve significant reductions in HbA1c (a marker of blood sugar control) and weight loss of around 314% of their body weight, depending on the medication and lifestyle changes
The animal studies are the basis for Food and Drug Administration warnings that both Ozempic approved only for diabetes but used off-label for weight loss as well as the higher-dose obesity formulation, Wegovy, should be discontinued at least two months prior to pregnancy
Overall, oral Semaglutide Tablet represents a valuable addition to the treatment options available for people with type 2 diabetes (T2D), offering the convenience of oral administration along with effective blood sugar control and potential benefits for weight management and cardiovascular health
In particular, T2D is poorly presented during childhood, while it is frequent in adult patients after the 5 th decade of life [17]
Smith, L.C., Hawley, T.S., Henson, J.H., Majeske, A.J., Oren, M
Acta Dermatovenerologica Croatica, 14(1), 0-0
